Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Biol Pharm Bull ; 20(4): 421-7, 1997 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9145222

RESUMEN

We evaluated the relationship between the cumulative amounts of 5 kinds of beta-blockers (alprenolol, oxprenolol, timolol, acebutolol and atenolol) permeating through the stratum corneum and a* values obtained by measuring the formation of erythema, a skin irritation reaction, with a chromameter after transdermal application of adhesive patches containing 2 beta-blocker to the skin of guinea pigs. The cumulative amount of beta-blocker released from each adhesive patch to the skin increased with the increase in application time. The contents of alprenolol, oxprenolol and timolol in the stratum corneum and in the stripped skin increased markedly up to 4 h after application and thereafter were maintained at high levels up to 24 h. The contents of acebutolol and atenolol, on the other hand, increased up to 24 h, but these values were low. a* values of all adhesive patches 24 h after application were higher than those before application. The correlation coefficients between the cumulative amounts of alprenolol, oxprenolol, timolol, acebutolol or atenolol permeating through the stratum corneum and (delta a* -delta a*Placebo) values were 0.739, 0.717, 0.722, 0.551 and 0.633, respectively. The correlation coefficient calculated by averaging the cumulative amounts of 6 kinds of beta-blockers permeating through the stratum corneum [including propranolol which was reported previously (Kobayashi I., et al., Biol. Pharm. Bull., 19, 839-844 (1996))] was 0.731, higher than the correlation coefficient between contents of these beta-blockers in the stripped skin and (delta a* -delta a*Placebo) values (r = 0.552). This suggests that there was a high correlation between the cumulative amounts of beta-blockers permeating through the stratum corneum and (delta a* -delta a*Placebo) values.


Asunto(s)
Antagonistas Adrenérgicos beta/metabolismo , Dermatitis Irritante/etiología , Absorción Cutánea , Piel/metabolismo , Acebutolol/administración & dosificación , Acebutolol/metabolismo , Acebutolol/toxicidad , Administración Cutánea , Antagonistas Adrenérgicos beta/administración & dosificación , Antagonistas Adrenérgicos beta/toxicidad , Alprenolol/administración & dosificación , Alprenolol/metabolismo , Alprenolol/toxicidad , Animales , Atenolol/administración & dosificación , Atenolol/metabolismo , Atenolol/toxicidad , Dermatitis Irritante/metabolismo , Cobayas , Masculino , Oxprenolol/administración & dosificación , Oxprenolol/metabolismo , Oxprenolol/toxicidad , Piel/efectos de los fármacos , Timolol/administración & dosificación , Timolol/metabolismo , Timolol/toxicidad
2.
Arch Toxicol ; 68(6): 375-84, 1994.
Artículo en Inglés | MEDLINE | ID: mdl-7916561

RESUMEN

Beta-adrenoceptor blockers are widely used drugs for the treatment of cardiovascular diseases. Since beta-blockers cross the placenta, it is essential to consider possible adverse effects on the embryo. Six beta-adrenoceptor blockers were tested at various concentrations (10-5000 microM) in a rat whole embryo culture. Although inducing a very similar pattern of dysmorphogenetic effects (incomplete flexure, disturbed development of the neural tube, the head, the heart and the tail bud), the compounds exhibited a wide range of embryotoxic potency. Estimation of the EC50 (median-concentration producing dysmorphogenesis in 50% of the embryos) for the six compounds revealed differences of more than two orders of magnitude: propranolol 25 microM, alprenolol 30 microM, metoprolol 100 microM, pindolol 150 microM, acebutolol 500 microM, atenolol 4000 microM. Measurements of the concentrations of the various drugs in the cultured embryos at corresponding EC50 levels showed differing values: metoprolol 4.5 microM, propranolol 5.2 microM, alprenolol 8.4 microM, pindolol 9.0 microM, acebutolol 12.5 microM and atenolol 77.0 microM. With regard to the EC50 and the degree of substance transfer to the embryo it can be stated that propranolol and metoprolol show a much higher intrinsic potency to interfere with normal in vitro embryonic development than, e.g. atenolol.


Asunto(s)
Antagonistas Adrenérgicos beta/toxicidad , Embrión de Mamíferos/efectos de los fármacos , Acebutolol/toxicidad , Antagonistas Adrenérgicos beta/farmacocinética , Alprenolol/toxicidad , Animales , Atenolol/toxicidad , Relación Dosis-Respuesta a Droga , Embrión de Mamíferos/patología , Desarrollo Embrionario y Fetal , Técnicas In Vitro , Metoprolol/toxicidad , Pindolol/toxicidad , Propranolol/toxicidad , Ratas , Ratas Wistar
3.
Fundam Appl Toxicol ; 6(3): 395-422, 1986 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-2870945

RESUMEN

The use of various beta-adrenergic blockers has become extensive as they have been found to be efficacious in the treatment of a number of cardiovascular problems including cardiac arrhythmias, angina pectoris, and hypertension. The widespread and chronic use of these drugs has generated a concern for their potential chronic toxicity. Eighteen beta-adrenergic blockers have been reviewed and the available literature pertaining to their potential carcinogenicity, mutagenicity, and teratogenicity has been summarized and compared.


Asunto(s)
Antagonistas Adrenérgicos beta/toxicidad , Acebutolol/toxicidad , Antagonistas Adrenérgicos beta/metabolismo , Antagonistas Adrenérgicos beta/farmacología , Alprenolol/toxicidad , Animales , Atenolol/toxicidad , Cocarcinogénesis , Etanolaminas/toxicidad , Femenino , Cinética , Labetalol/toxicidad , Dosificación Letal Mediana , Masculino , Metoprolol/toxicidad , Ratones , Mutágenos , Nadolol , Neoplasias Experimentales/inducido químicamente , Oxprenolol/toxicidad , Pindolol/toxicidad , Practolol/toxicidad , Propanolaminas/toxicidad , Propranolol/toxicidad , Ratas , Sotalol/toxicidad , Timolol/toxicidad
4.
Acta Pharmacol Toxicol (Copenh) ; 58(1): 55-60, 1986 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-3953295

RESUMEN

The ulcerogenic effect of five different salts of alprenolol were tested against placebo in a porcine oesophageal test model. The salts with high water solubility, such as the hydrochloride and the fumarate, gave rise to the highest plasma concentrations of alprenolol and evoked serious oesophageal lesions, while the salts with low solubility-the benzoate, maleate and sebacate-had no irritative effect on the oesophagus. The plasma levels of alprenolol were much higher following administration of alprenolol hydrochloride in the oesophagus than after an identical intraduodenal dose of the same salt possibly because of the avoidance of the first-pass degradation during oesophageal absorption.


Asunto(s)
Alprenolol/toxicidad , Enfermedades del Esófago/inducido químicamente , Absorción , Alprenolol/administración & dosificación , Alprenolol/sangre , Animales , Endoscopía , Enfermedades del Esófago/patología , Esófago/patología , Femenino , Masculino , Solubilidad , Porcinos , Comprimidos , Úlcera/inducido químicamente , Úlcera/patología
5.
Acta Pharmacol Toxicol (Copenh) ; 53(5): 385-91, 1983 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-6140813

RESUMEN

Drug-induced oesophageal lesions have attracted increasing attention during the past few years. A test model is presented for assessing irritative or ulcerogenic effects of potential drugs on the oesophagus. In this model the pig oesophagus is used, as it is more similar to the human oesophagus than models used in other techniques that have been suggested. The beta-blockers, alprenolol and propranolol, displayed the same ulcerogenic properties with this test model as reported with other test models in the literature. The beta 1-selective blocker metoprolol, did not have such ulcerogenic effects. The pig model is suggested as the method of choice in evaluating the potential irritative or ulcerogenic effects of pharmaceutical formulations intended for human use.


Asunto(s)
Antagonistas Adrenérgicos beta/toxicidad , Enfermedades del Esófago/inducido químicamente , Alprenolol/toxicidad , Animales , Enfermedades del Esófago/patología , Esófago/patología , Femenino , Masculino , Metoprolol/toxicidad , Propranolol/toxicidad , Porcinos , Úlcera/inducido químicamente , Úlcera/patología
7.
Eur Surg Res ; 12(4): 270-82, 1980.
Artículo en Inglés | MEDLINE | ID: mdl-7250155

RESUMEN

This article presents an experimental method using cats for investigation of the local ulcerogenic properties of oral drugs in the esophagus. 15 drugs in current clinical use were tested. The drugs were placed in esophagus and the animals were sacrificed after 5--8 h, 4--7 or 21 days. The esophagus was cut open, photographed macroscopically and sectioned for light microscopy. Several drugs, e.g. doxycycline, alprenolol, propranolol, ferrosuccinate, ferrosulfate, and emepronium bromide showed marked ulcerogenic properties, whereas indomethacin and betamethasone did not cause any lesions in the cat esophagus. The results seem to be in accordance with the local effect these same drugs exert on the human esophageal mucosa. In order to predict and prevent drug-induced esophageal lesions in man we suggest that oral drugs should be tested concerning their local ulcerogenic properties in the esophagus.


Asunto(s)
Enfermedades del Esófago/inducido químicamente , Administración Oral , Alprenolol/toxicidad , Analgésicos/toxicidad , Animales , Gatos , Doxiciclina/toxicidad , Esófago/patología , Concentración de Iones de Hidrógeno , Hierro/toxicidad , Cloruro de Potasio/toxicidad , Factores de Tiempo , Úlcera/inducido químicamente
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA